ETOPOSIDE Side Effects

6638057-X | Anaemia, Dizziness, Dyspnoea, Fatigue, Neutropenia, Orthostatic Hypotension, Pulmonary Radiation Injury, Respiratory Failure
on Mar 05, 2010 Male patient from UNITED STATES , 60 years of age, weighting 218.3 lb, was diagnosed with non-small cell lung cancer stage iii and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dizziness (What is dizziness?), dyspnoea, fatigue, neutropenia, orthostatic hypotension, pulmonary radiation injury, respiratory failure. Etoposide dosage: 113mg Iv. Patient was hospitalized.

6636525-8 | Acute Myeloid Leukaemia, Disease Complication, Myelodysplastic Syndrome
Patient was taking Etoposide (View Usage). Patient had the following side effects: acute myeloid leukaemia, disease complication, myelodysplastic syndrome on Mar 01, 2010 from UNITED STATES Additional patient health information: Male patient , 16 years of age, was diagnosed with ewing's sarcoma and. Etoposide dosage: . During the same period patient was treated with IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), RUBITECAN (Inhalation) (View Rubitecan Review and Rubitecan Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ).

6636436-8 | Multi-organ Failure, Myeloid Leukaemia
Adverse event was reported on Mar 01, 2010 by a Female patient taking Etoposide (View Usage) (Dosage: ) was diagnosed with primitive neuroectodermal tumour and. Location: UNITED STATES , 15 years of age, After Etoposide was administered, patient had the following side effects: multi-organ failure, myeloid leukaemia. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), (LOMUSTINE) (View (lomustine) Review and (lomustine) Label ), (NITROGEN MUSTARD) (View (nitrogen Mustard) Review and (nitrogen Mustard) Label ), (PROCARBAZINE) (View (procarbazine) Review and (procarbazine) Label ).

6627217-X | Hepatitis B
on Mar 04, 2010 Female patient from TURKEY , 35 years of age, was diagnosed with choriocarcinoma and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). Etoposide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).


6624064-X | Disease Recurrence, Hepatitis B, International Normalised Ratio Increased
on Feb 16, 2010 Female patient from TURKEY , 35 years of age, was diagnosed with choriocarcinoma and was treated with Etoposide (View Usage). Patient had the following side effects: disease recurrence, hepatitis b (What is hepatitis b?), international normalised ratio increased. Etoposide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DACTINOMYCIN (DACTINOMYCIN) (DACTINOMYCIN) (View Dactinomycin (dactinomycin) (dactinomycin) Review and Dactinomycin (dactinomycin) (dactinomycin) Label ).

6623432-X | Dysponesis, Neutropenia, Respiratory Failure
Patient was taking Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: dysponesis, neutropenia, respiratory failure on Feb 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 17 years of age, was diagnosed with acute lymphocytic leukaemia and. Etoposide dosage: 100 Mg/m2, 1 Day, Intravenous. During the same period patient was treated with (CLOFARABINE) (40 Mg/m2, 1 Day, Intravenous) (View (clofarabine) Review and (clofarabine) Label ), CYCLOPHOSPHAMIDE (440 Mg/m2, 1 Day, Intravenous) (View Cyclophosphamide Review and Cyclophosphamide Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), (CETRIZINE) (View (cetrizine) Review and (cetrizine) Label ), (CO TRIMAZOLE) (View (co-trimazole) Review and (co-trimazole) Label ), (LEVOMEPROMAZINE) (View (levomepromazine) Review and (levomepromazine) Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), (PARACETAMOL) (View (paracetamol) Review and (paracetamol) Label ). Patient was hospitalized.

6617103-3 | Thrombocytopenia, Tumour Haemorrhage
Adverse event was reported on Feb 23, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: ) was diagnosed with testicular choriocarcinoma stage iii and. Location: JAPAN , 28 years of age, Patient experienced the following unwanted or unexpected effects: thrombocytopenia, tumour haemorrhage. During the same period patient was treated with BLEOMYCIN SULFATE (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6617091-X | Hepatitis B, Liver Disorder
on Feb 22, 2010 Male patient from SPAIN , 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Etoposide (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?), liver disorder. Etoposide dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6617078-7 | Acute Respiratory Distress Syndrome, Pancytopenia, Septic Shock
on Feb 22, 2010 Male patient from AUSTRIA , 13 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: acute respiratory distress syndrome, pancytopenia, septic shock. Etoposide dosage: . During the same period patient was treated with CYTARABINE (1 Df= Six Doses Of Cytarabine 3 G/m2 And Four Doses Of Cytarabine 40 Mg I.t.) (View Cytarabine Review and Cytarabine Label ), ALL TRANS RETINOIC ACID (View All-trans-retinoic Acid Review and All-trans-retinoic Acid Label ).

6616686-7 | Anaemia, Asthenia, Fatigue, Neutropenia, Orthostatic Hypotension, Respiratory Failure
Patient was taking Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, fatigue, neutropenia, orthostatic hypotension, respiratory failure on Feb 17, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 218.3 lb, was diagnosed with non-small cell lung cancer stage iii and. Etoposide dosage: 113mg Iv. Patient was hospitalized.

6613846-6 | Gangrene, Peripheral Ischaemia
Adverse event was reported on Feb 24, 2010 by a Female patient taking Etoposide (View Usage) (Dosage: ) was diagnosed with lymphoma (What is lymphoma?) and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: gangrene, peripheral ischaemia. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), FAMVIR (View Famvir Review and Famvir Label ), INSULIN (View Insulin Review and Insulin Label ).

6613690-X | Constipation, Cryptosporidiosis Infection, Culture Stool Positive, Gastrointestinal Stoma Complication, Megacolon, Pneumatosis, Trichuriasis
on Feb 09, 2010 Female patient from UNITED STATES , child 5 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: constipation (What is constipation?), cryptosporidiosis infection, culture stool positive, gastrointestinal stoma complication, megacolon, pneumatosis, trichuriasis. Etoposide dosage: . During the same period patient was treated with THIOGUANINE (View Thioguanine Review and Thioguanine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6608870-3 | Arterial Thrombosis Limb
on Feb 15, 2010 Male patient from FRANCE , 34 years of age, was diagnosed with seminoma and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis limb. Etoposide dosage: 100 Mg/m2/day For 5 Days; 3 Cycles. During the same period patient was treated with CISPLATIN (20 Mg/m2/day For 5 Days; 3 Cycles) (View Cisplatin Review and Cisplatin Label ), BLEOMYCIN SULFATE (30 Mg/day, Days 1, 8 And 15; 3 Cycles) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6608861-2 | Arterial Thrombosis Limb
Patient was taking Etoposide (View Usage). Patient had the following side effects: arterial thrombosis limb on Feb 15, 2010 from FRANCE Additional patient health information: Male patient , 36 years of age, was diagnosed with testicular seminoma (pure) and. Etoposide dosage: 100 Mg/m2/day For 5 Days; 4 Cycles. During the same period patient was treated with CISPLATIN (20 Mg/m2/day For 5 Days; 4 Cycles) (View Cisplatin Review and Cisplatin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6607325-X | Hepatitis B
Adverse event was reported on Feb 16, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: ) was diagnosed with choriocarcinoma and. Location: TURKEY , 35 years of age, After Etoposide was administered, patient had the following side effects: hepatitis b (What is hepatitis b?). During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ).

6605164-7 | Arterial Thrombosis, Peripheral Ischaemia
on Feb 16, 2010 Male patient from FRANCE , 34 years of age, was diagnosed with testis cancer and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis, peripheral ischaemia. Etoposide dosage: 100 Mg/m2, Daily. During the same period patient was treated with PREDNISOLONE ACETATE (WATSON LABORATORIES) (420 Mg, Unk) (View Prednisolone Acetate (watson Laboratories) Review and Prednisolone Acetate (watson Laboratories) Label ), CISPLATIN (20 Mg/m2, Daily) (View Cisplatin Review and Cisplatin Label ), BLEOMYCIN SULFATE (30 Mg, Daily Days 1, 8, And 15) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ).

6605163-5 | Arterial Thrombosis, Peripheral Ischaemia
on Feb 16, 2010 Male patient from FRANCE , 36 years of age, was diagnosed with testis cancer and was treated with Etoposide (View Usage). Patient had the following side effects: arterial thrombosis, peripheral ischaemia. Etoposide dosage: 100 Mg/m2, Daily. During the same period patient was treated with PREDNISOLONE ACETATE (WATSON LABORATORIES) (420 Mg, Unk) (View Prednisolone Acetate (watson Laboratories) Review and Prednisolone Acetate (watson Laboratories) Label ), CISPLATIN (20 Mg/m2, Daily) (View Cisplatin Review and Cisplatin Label ).

6604999-4 | Cystitis Haemorrhagic
Patient was taking Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: cystitis haemorrhagic on Feb 18, 2010 from GERMANY Additional patient health information: Female patient , weighting 131.6 lb, . Etoposide dosage: . During the same period patient was treated with TREOSULFAN (View Treosulfan Review and Treosulfan Label ), ANTI THYMOCYTE GLOBULIN NOS (View Anti-thymocyte Globulin Nos Review and Anti-thymocyte Globulin Nos Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6601791-1 | Blood Urine Present, Exchange Blood Transfusion, Haemolytic Anaemia, Haemolytic Uraemic Syndrome, Petechiae, Renal Failure Acute, Thrombocytopenia
Adverse event was reported on Feb 15, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: 100 Mg, Unk) was diagnosed with acute lymphocytic leukaemia and. Location: JAPAN , 14 years of age, Patient experienced the following unwanted or unexpected effects: blood urine present, exchange blood transfusion, haemolytic anaemia, haemolytic uraemic syndrome, petechiae, renal failure acute, thrombocytopenia. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DECADRON #1 (View Decadron #1 Review and Decadron #1 Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), LEUNASE (View Leunase Review and Leunase Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6591268-4 | Hepatitis B
on Feb 15, 2010 Female patient from TURKEY , 35 years of age, was diagnosed with choriocarcinoma and was treated with Etoposide (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?). Etoposide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6589113-6 | Brain Scan Abnormal, Corona Virus Infection, Headache, Hepatitis Cholestatic, Hypertension, Ileus, Loss Of Consciousness, Mucosal Inflammation, Neutropenic Colitis
on Jan 18, 2010 Male patient from UNITED KINGDOM , child 11 years of age, weighting 82.67 lb, was diagnosed with acute leukaemia and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: brain scan abnormal, corona virus infection, headache (What is headache?), hepatitis cholestatic, hypertension, ileus, loss of consciousness, mucosal inflammation, neutropenic colitis. Etoposide dosage: 100. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), (CLOFARABINE) (40 Mg/m2 Intravenous) (View (clofarabine) Review and (clofarabine) Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), (TEICOPLANIN) (View (teicoplanin) Review and (teicoplanin) Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6589006-4 | Neutropenic Sepsis
Patient was taking Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenic sepsis on Jan 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 63 years of age, weighting 176.4 lb, was diagnosed with small cell lung cancer metastatic and. Etoposide dosage: 210 Mg, 1 Total, Intravenous. During the same period patient was treated with CISPLATIN (133 Mg, 1 Total, Intravenous) (View Cisplatin Review and Cisplatin Label ).

6587930-X | Injection Site Oedema, Localised Oedema
Adverse event was reported on Feb 17, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: 126 Every Day Iv) . Location: UNITED STATES , 56 years of age, weighting 375.2 lb, Patient had the following side effects: injection site oedema, localised oedema. Patient was hospitalized.

6582586-4 | Anaemia, Chest Discomfort, Chest Pain, Fatigue
on Feb 12, 2010 Male patient from UNITED STATES , 63 years of age, was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: anaemia, chest discomfort, chest pain (What is chest pain?), fatigue. Etoposide dosage: 190 Mg Other Iv. Patient was hospitalized.

6580990-1 | Arterial Thrombosis, Peripheral Ischaemia
on Feb 01, 2010 Male patient from JAPAN , 36 years of age, was diagnosed with seminoma and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis, peripheral ischaemia. Etoposide dosage: 100mg/m2/day For Five Days. During the same period patient was treated with CISPLATIN (20mg/m2/day For 5 Days) (View Cisplatin Review and Cisplatin Label ), PREDNISOLONE (Received More Than 420mg) (View Prednisolone Review and Prednisolone Label ).

6580989-5 | Arterial Thrombosis, Peripheral Ischaemia
Patient was taking Etoposide (View Usage). Patient had the following side effects: arterial thrombosis, peripheral ischaemia on Feb 01, 2010 from JAPAN Additional patient health information: Male patient , 34 years of age, was diagnosed with testis cancer and. Etoposide dosage: Route Dr; Cyclical For 5 Days. During the same period patient was treated with CISPLATIN (Route Dr; Cyclical- For 5 Days) (View Cisplatin Review and Cisplatin Label ), BLEOMYCIN SULFATE (Cyclical On Day1, 8,15; Route Dr) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), PREDNISOLONE (Received More Than 420 Mg) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6575705-7 | Bone Marrow Failure, Encephalitis, Gastrointestinal Disorder, Haemolysis, Mucosal Inflammation, Renal Failure Acute, Thrombotic Microangiopathy
Adverse event was reported on Feb 01, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: Route:dr Cycle 4) was diagnosed with cns germinoma and. Location: JAPAN , 22 years of age, After Etoposide was administered, patient had the following side effects: bone marrow failure, encephalitis (What is encephalitis?), gastrointestinal disorder, haemolysis, mucosal inflammation, renal failure acute, thrombotic microangiopathy. During the same period patient was treated with CISPLATIN (Route:dr Cyc 4) (View Cisplatin Review and Cisplatin Label ), BLEOMYCINE BELLON (Route:dr Cuyc 4) (View Bleomycine Bellon Review and Bleomycine Bellon Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

6574226-5 | Acute Lymphocytic Leukaemia, Bacteraemia, Convulsion, Corona Virus Infection, Enterococcal Bacteraemia, Headache, Hepatitis Cholestatic, Hypertension, Ileus
on Jan 18, 2010 Male patient from UNITED KINGDOM , child 11 years of age, weighting 82.67 lb, was diagnosed with acute lymphocytic leukaemia recurrent and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: acute lymphocytic leukaemia, bacteraemia, convulsion, corona virus infection, enterococcal bacteraemia, headache (What is headache?), hepatitis cholestatic, hypertension, ileus. Etoposide dosage: 100 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CLOFARABINE (40 Mg/m2 Intravenous) (View Clofarabine Review and Clofarabine Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6573917-X | Hypophagia, Hypotension, Lethargy, Nausea
on Feb 04, 2010 Female patient from UNITED STATES , weighting 102.5 lb, was treated with Etoposide (View Usage). Patient had the following side effects: hypophagia, hypotension, lethargy, nausea (What is nausea?). Etoposide dosage: 320 Mg. During the same period patient was treated with PREDNISONE (960 Mg) (View Prednisone Review and Prednisone Label ), RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) (600 Mg) (View Rituximab (moab C2b8 Anti Cd20, Chimeric) Review and Rituximab (moab C2b8 Anti Cd20, Chimeric) Label ), VINCRISTINE SULFATE (2.56 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CYCLOPHOSPHAMIDE (1200 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (64 Mg) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

6572209-2 | Myelitis Transverse
Patient was taking Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: myelitis transverse on Jan 25, 2010 from UNITED STATES Additional patient health information: Male patient , 15 years of age, was diagnosed with sarcoma and. Etoposide dosage: Unk. During the same period patient was treated with VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACTINOMYCIN D (Unk) (View Actinomycin D Review and Actinomycin D Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (Unk) (View Cisplatin Review and Cisplatin Label ), DTIC /00372801/ (Unk) (View Dtic /00372801/ Review and Dtic /00372801/ Label ).

6572208-0 | Myelitis Transverse
Adverse event was reported on Jan 25, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: Unk) was diagnosed with sarcoma and. Location: UNITED STATES , child 6 years of age, Patient experienced the following unwanted or unexpected effects: myelitis transverse. During the same period patient was treated with VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACTINOMYCIN D (Unk) (View Actinomycin D Review and Actinomycin D Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (Unk) (View Cisplatin Review and Cisplatin Label ), DTIC /00372801/ (Unk) (View Dtic /00372801/ Review and Dtic /00372801/ Label ).

6572206-7 | Myelitis Transverse
on Jan 25, 2010 Female patient from UNITED STATES , 14 years of age, was diagnosed with sarcoma and was treated with Etoposide (View Usage). Patient had the following side effects: myelitis transverse. Etoposide dosage: Unk. During the same period patient was treated with VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACTINOMYCIN D (Unk) (View Actinomycin D Review and Actinomycin D Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (Unk) (View Cisplatin Review and Cisplatin Label ), DTIC /00372801/ (Unk) (View Dtic /00372801/ Review and Dtic /00372801/ Label ).

6572060-3 | Myelitis Transverse
on Jan 25, 2010 Male patient from UNITED STATES , 17 years of age, was diagnosed with sarcoma and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: myelitis transverse. Etoposide dosage: Unk. During the same period patient was treated with VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACTINOMYCIN D (Unk) (View Actinomycin D Review and Actinomycin D Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (Unk) (View Cisplatin Review and Cisplatin Label ).

6570313-6 | Abdominal Pain, Nausea
Patient was taking Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?) on Feb 02, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Etoposide dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6554000-6 | Anaemia, Asthenia, Infection, Neutropenia, Orthostatic Hypotension, Respiratory Failure
Adverse event was reported on Jan 14, 2010 by a Male patient taking Etoposide (View Usage) (Dosage: 113mg Iv) was diagnosed with non-small cell lung cancer stage iii and. Location: UNITED STATES , 60 years of age, weighting 218.3 lb, Patient had the following side effects: anaemia, asthenia, infection (What is infection?), neutropenia, orthostatic hypotension, respiratory failure. Patient was hospitalized.

6550274-6 | Abdominal Discomfort, Abdominal Tenderness, Computerised Tomogram Abnormal, Corona Virus Infection, Diarrhoea, Enterococcal Infection, Headache, Hepatitis Cholestatic, Hypertension
on Jan 18, 2010 Male patient from UNITED KINGDOM , child 11 years of age, weighting 82.67 lb, was diagnosed with leukaemia recurrent and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: abdominal discomfort, abdominal tenderness, computerised tomogram abnormal, corona virus infection, diarrhoea, enterococcal infection, headache (What is headache?), hepatitis cholestatic, hypertension. Etoposide dosage: . During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6543200-7 | Abdominal Discomfort, Abdominal Tenderness, Diarrhoea, Headache, Hepatitis Cholestatic, Hypertension, Ileus, Loss Of Consciousness, Nausea
on Jan 15, 2010 Male patient from UNITED KINGDOM , child 11 years of age, weighting 83.78 lb, was diagnosed with acute lymphocytic leukaemia recurrent, constipation (What is constipation?), diarrhoea, nausea (What is nausea?), gastrointestinal disorder and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, abdominal tenderness, diarrhoea, headache (What is headache?), hepatitis cholestatic, hypertension, ileus, loss of consciousness, nausea (What is nausea?). Etoposide dosage: Dosages/interval: 5/. During the same period patient was treated with CYCLOPHOSPHAMIDE (Dosages 5/) (View Cyclophosphamide Review and Cyclophosphamide Label ), EVOLTRA (View Evoltra Review and Evoltra Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6531655-3 | Chronic Myeloid Leukaemia
Patient was taking Etoposide (View Usage). Patient had the following side effects: chronic myeloid leukaemia on Jan 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 54 years of age, was diagnosed with acute lymphocytic leukaemia and. Etoposide dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ELSPAR (View Elspar Review and Elspar Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ).

6491977-1 | Brain Oedema, Cerebral Infarction, Cerebral Venous Thrombosis, Grand Mal Convulsion, Hemiparesis
Adverse event was reported on Nov 24, 2009 by a Female patient taking Etoposide (View Usage) (Dosage: ) was diagnosed with choriocarcinoma and. Location: INDIA , 30 years of age, After Etoposide was administered, patient had the following side effects: brain oedema, cerebral infarction, cerebral venous thrombosis, grand mal convulsion, hemiparesis. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ACTINOMYCIN D (View Actinomycin D Review and Actinomycin D Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

6484921-4 | Mucosal Inflammation, Neutropenic Sepsis, Renal Failure Acute, Toxic Epidermal Necrolysis
on Nov 23, 2009 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with gestational trophoblastic tumour, metastasis and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: mucosal inflammation, neutropenic sepsis, renal failure acute, toxic epidermal necrolysis. Etoposide dosage: 100mg/m2. During the same period patient was treated with CISPLATIN (20mg/m2) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6480885-8 | Cerebral Infarction, Venous Thrombosis
on Nov 24, 2009 Female patient from INDIA , 30 years of age, was diagnosed with choriocarcinoma and was treated with Etoposide (View Usage). Patient had the following side effects: cerebral infarction, venous thrombosis. Etoposide dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ).

6479640-4 | Malignant Neoplasm Progression, Mediastinal Disorder, Non-hodgkin's Lymphoma Stage Iii, Pleural Effusion
Patient was taking Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: malignant neoplasm progression, mediastinal disorder, non-hodgkin's lymphoma stage iii, pleural effusion on Dec 04, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 13 years of age, weighting 105.7 lb, was diagnosed with non-hodgkin's lymphoma, t-cell lymphoma and. Etoposide dosage: 100 Mg/m2, 1 Day, Intravenous. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), NELARABINE (910 Mg, 1 Day,) (View Nelarabine Review and Nelarabine Label ), ERWINASE (View Erwinase Review and Erwinase Label ), CLOFARABINE (40 Mg/m2, 1 Day, Intravenous) (View Clofarabine Review and Clofarabine Label ).

6474928-5 | Thrombotic Cerebral Infarction
Adverse event was reported on Nov 24, 2009 by a Female patient taking Etoposide (View Usage) (Dosage: Unk) was diagnosed with choriocarcinoma and. Location: INDIA , 30 years of age, Patient experienced the following unwanted or unexpected effects: thrombotic cerebral infarction. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), ACTINOMYCIN D (View Actinomycin D Review and Actinomycin D Label ).

6454736-1 | Small Intestinal Perforation
on Nov 16, 2009 Male patient from SOUTH AFRICA , 32 years of age, was diagnosed with testicular cancer metastatic and was treated with Etoposide (View Usage). Patient had the following side effects: small intestinal perforation. Etoposide dosage: Unk. During the same period patient was treated with BLEOMYCIN SULFATE (Unk) (View Bleomycin Sulfate Review and Bleomycin Sulfate Label ), CISPLATIN (Unk) (View Cisplatin Review and Cisplatin Label ).

6446380-7 | Aspiration, Haematemesis, Haemoglobin Decreased, Hypoxia, Platelet Count Decreased
on Nov 04, 2009 Male patient from UNITED STATES , 48 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer stage iii and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: aspiration, haematemesis, haemoglobin decreased, hypoxia, platelet count decreased. Etoposide dosage: 86.5mg Iv. Patient was hospitalized.

6446314-5 | Acute Respiratory Failure, Febrile Neutropenia, Pneumonia, Renal Failure Acute, Septic Shock
Patient was taking Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, febrile neutropenia, pneumonia (What is pneumonia?), renal failure acute, septic shock on Nov 06, 2009 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 103.6 lb, was diagnosed with non-small cell lung cancer stage iii and. Etoposide dosage: 500mg/m2. Patient was hospitalized.

6445599-9 | Dehydration, Hypokalaemia, Syncope
Adverse event was reported on Nov 18, 2009 by a Female patient taking Etoposide (View Usage) (Dosage: 156 Mg) . Location: UNITED STATES , weighting 130.3 lb, Patient had the following side effects: dehydration, hypokalaemia, syncope. During the same period patient was treated with CISPLATIN (124mg) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6443515-7 | Anaemia, Blast Cell Count Increased, Bone Marrow Transplant, Dysplasia, Granulocytes Abnormal, Thrombocytopenia, White Blood Cell Morphology Abnormal
on Nov 04, 2009 Male patient from UNITED STATES , 43 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide (View Usage). After Etoposide was administered, patient had the following side effects: anaemia, blast cell count increased, bone marrow transplant (What is bone marrow transplant?), dysplasia, granulocytes abnormal, thrombocytopenia, white blood cell morphology abnormal. Etoposide dosage: . During the same period patient was treated with BUSULFAN (View Busulfan Review and Busulfan Label ).

6435205-1 | Neutropenic Sepsis, Toxic Epidermal Necrolysis
on Oct 27, 2009 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with malignant hydatidiform mole, chronic obstructive pulmonary disease and was treated with Etoposide (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenic sepsis, toxic epidermal necrolysis. Etoposide dosage: 100 Mg/m2 On Days 1 And 2 For Metastatic Gestational Trophoblastic Neoplasia. During the same period patient was treated with CISPLATIN (20 Mg/m2 On Days 1 And 2 For Metastatic Gestational Trophoblastic Neoplasia) (View Cisplatin Review and Cisplatin Label ), METHOTREXATE (Dosage Not Stated) (View Methotrexate Review and Methotrexate Label ), CYCLOPHOSPHAMIDE (Dosage Not Stated) (View Cyclophosphamide Review and Cyclophosphamide Label ), ONCOVIN (Dosage Not Stated) (View Oncovin Review and Oncovin Label ), ACTINOMYCINES (View Actinomycines Review and Actinomycines Label ), SALBUTAMOL W/BECLOMETASONE (Dosage Not Stated) (View Salbutamol W/beclometasone Review and Salbutamol W/beclometasone Label ).

6431672-8 | Dyspnoea, Infection, Neutropenia, Pyrexia, Respiratory Failure
Patient was taking Etoposide (View Usage). Patient had the following side effects: dyspnoea, infection (What is infection?), neutropenia, pyrexia, respiratory failure on Oct 20, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 17 years of age, was diagnosed with acute lymphocytic leukaemia and. Etoposide dosage: 100 Mg/m2, 1 Day,. During the same period patient was treated with CLOFARABINE (40 Mg/m2, 1 Day,) (View Clofarabine Review and Clofarabine Label ), CYCLOPHOSPHAMIDE (440 Mg/m2, 1 Day,) (View Cyclophosphamide Review and Cyclophosphamide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CETRIZINE (View Cetrizine Review and Cetrizine Label ), CO TRIMAZOLE (View Co-trimazole Review and Co-trimazole Label ), LEVOMEPROMAZINE (View Levomepromazine Review and Levomepromazine Label ). Patient was hospitalized.